Background Neurologically-based muscle weakness is a common symptom in people with
multiple sclerosis MS (MS), who may also exhibit muscle morphology changes and intrinsic …

A number of environmental toxicants are noted for their activity that leads to declined motor
function. However, the role of muscle as a proximal toxicity target organ for environmental …

Background Recent studies reported that an increase in intramuscular adipose tissue of the
quadriceps in older patients negatively affects the recovery of activities of daily living (ADL) …

Introduction Sarcopenia is highly prevalent in geriatric rehabilitation patients. Resistance
exercise training (RET) combined with protein supplementation is recommended to increase …

Introduction Changes in skeletal muscle mass affect physical performance in chronic stroke
survivors. The skeletal muscle mass index is thus an important assessment factor in stroke; …

Background Research on the gut microbiota has emerged as a new direction for
understanding pathophysiologic changes in diseases associated with aging, such as …

Background Sarcopenia has a significant medical and economic impact. Serum fibroblast
growth factor 19 (FGF19) has recently been described as promoting muscle mass and …

Sarcopenia has been described as a muscle disease, with multiple adverse consequences
on human health. Recommendations aimed at supporting awareness, prevention, early …

Background Sarcopenia and diabetes are both prevalent health problems worldwide.
However, little is known about the relationship between prediabetes and the prevalence and …

Background There is a need to adopt valid techniques to assess skeletal muscle (SM) in
clinical practice. SM can be precisely quantified from computed tomography (CT) images …